These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7396458)

  • 21. Susceptibility of 114 isolates of the Bacteroides fragilis group to imipenem and eight other antimicrobial agents.
    Downes J; Andrew JH
    Pathology; 1988 Jul; 20(3):260-3. PubMed ID: 3205597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe.
    Hedberg M; Nord CE;
    Clin Microbiol Infect; 2003 Jun; 9(6):475-88. PubMed ID: 12848722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro susceptibilities of the Bacteroides fragilis group to 14 antimicrobial agents in Korea.
    Lee K; Jang IH; Kim YJ; Chong Y
    Antimicrob Agents Chemother; 1992 Jan; 36(1):195-7. PubMed ID: 1590688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1989.
    Cuchural GJ; Snydman DR; McDermott L; Iannini PB; Hill GB; Cleary TJ; O'Keefe JP; Pierson CL; Rihs JD; Finegold SM
    Clin Ther; 1992; 14(1):122-36. PubMed ID: 1576621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic susceptibility of the subspecies of Bacteroides fragilis.
    Blazevic DJ
    Antimicrob Agents Chemother; 1976 Mar; 9(3):481-4. PubMed ID: 1259403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989.
    Betriu C; Cabronero C; Gomez M; Picazo JJ
    Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):352-6. PubMed ID: 1396757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of VITEK MS, Clin-ToF-II MS, Autof MS 1000 and VITEK 2 ANC card for identification of Bacteroides fragilis group isolates and antimicrobial susceptibilities of these isolates in a Chinese university hospital.
    Wang Y; Chen XF; Xie XL; Xiao M; Yang Y; Zhang G; Zhang JJ; Duan SM; Zhang Q; Zhang P; Tsui C; Xu YC
    J Microbiol Immunol Infect; 2019 Jun; 52(3):456-464. PubMed ID: 30772212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Isolation of anaerobic bacteria from clinical specimens and the drug susceptibility of Bacteroides fragilis].
    Ho SW; Hsien WC
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1977 Jun; 10(1-2):8-13. PubMed ID: 578133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents.
    Betriu C; Campos E; Cabronero C; Rodriguez-Avial C; Picazo JJ
    Antimicrob Agents Chemother; 1990 Apr; 34(4):671-3. PubMed ID: 2344174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survey of the susceptibility patterns of Bacteroides fragilis group strains in France from 1977 to 1992.
    Dubreuil L; Breuil J; Dublanchet A; Sedallian A
    Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):1094-9. PubMed ID: 1295764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of newer beta-lactam agents against clinical isolates of Bacteroides fragilis and other Bacteroides species.
    O'Keefe JP; Venezio FR; DiVincenzo CA; Shatzer KL
    Antimicrob Agents Chemother; 1987 Dec; 31(12):2002-4. PubMed ID: 3439807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial susceptibility testing of anaerobic bacteria.
    Rosenblatt JE
    Rev Infect Dis; 1984; 6 Suppl 1():S242-8. PubMed ID: 6372033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early susceptibility test results with the Bacteroides fragilis group.
    Aldridge KE
    J Antimicrob Chemother; 1993 Dec; 32(6):910-2. PubMed ID: 8144437
    [No Abstract]   [Full Text] [Related]  

  • 34. The in-vitro susceptibility of the Bacteroides fragilis group to amoxycillin-clavulanic acid.
    Brown EM
    J Antimicrob Chemother; 1984 Oct; 14(4):367-72. PubMed ID: 6501130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis group.
    Cuchural GJ; Tally FP; Jacobus NV; Cleary T; Finegold SM; Hill G; Iannini P; O'Keefe JP; Pierson C
    Antimicrob Agents Chemother; 1990 Mar; 34(3):479-80. PubMed ID: 2334161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation.
    Cuchural GJ; Tally FP; Jacobus NV; Aldridge K; Cleary T; Finegold SM; Hill G; Iannini P; O'Keefe JP; Pierson C
    Antimicrob Agents Chemother; 1988 May; 32(5):717-22. PubMed ID: 3395102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergence of carbapenem resistance in Bacteroides fragilis in China.
    Gao Q; Wu S; Xu T; Zhao X; Huang H; Hu F
    Int J Antimicrob Agents; 2019 Jun; 53(6):859-863. PubMed ID: 30831235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survey of Bacteroides fragilis susceptibility patterns in France.
    Breuil J; Burnat C; Patey O; Dublanchet A
    J Antimicrob Chemother; 1989 Jul; 24(1):69-75. PubMed ID: 2777729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Susceptibility of the Bacteroides fragilis group to 10 antibiotics. Results of 4 laboratories in Austria].
    Mittermayer H; Rotter M; Riezinger F; Thiel W; Stanek G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Nov; 262(4):500-11. PubMed ID: 3799095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitivity of Bacteroides fragilis to seven antimicrobial agents.
    Oitmaa M; Benn R
    Pathology; 1981 Oct; 13(4):697-703. PubMed ID: 7335376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.